The polymorphism of YWHAE, a gene encoding 14-3-3epsilon, and brain morphology in schizophrenia: A voxel-based morphometric study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kido, Mikio ^a   Nakamura, Yukako ^b   Nemoto, Kiyotaka ^c   Takahashi, Tsutomu ^a,e   Aleksic, Branko ^b   Furuichi, Atsushi ^a   Nakamura, Yumiko ^a   Ikeda, Masashi ^d,e   Noguchi, Kyo ^a   Kaibuchi, Kozo ^b,e   Iwata, Nakao ^d,e   Ozaki, Norio ^b,e   Suzuki, Michio ^a,e  

^a UNIVERSITY OF TOYAMA   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALLELE; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; DISC1 GENE; FEMALE; GENE; GENETIC VARIABILITY; GENOTYPE; GRAY MATTER; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; HUMAN; INSULA; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PUTAMEN; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VOXEL BASED MORPHOMETRY; YWHAE GENE; ANALYSIS OF VARIANCE; GENETICS; JAPAN; PATHOLOGY;

DISC1 PROTEIN, HUMAN; NERVE PROTEIN; PROTEIN 14 3 3; YWHAE PROTEIN, HUMAN;

14-3-3 PROTEINS; ADULT; ANALYSIS OF VARIANCE; FEMALE; GENOTYPE; GRAY MATTER; HIPPOCAMPUS; HUMANS; JAPAN; MAGNETIC RESONANCE IMAGING; MALE; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA;

EID: 84905658994     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103571     Document Type: Article

References (63)

1. Harrison PJ, Weinberger DR (2005) Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68. (Pubitemid 40139588)
2. Sawa A, Snyder SH (2002) Schizophrenia: diverse approaches to a complex disease. Science 296: 692-695. (Pubitemid 34441987)
3. Shenton ME, Dickey CC, Frumin M, McCarley RW (2001) A review of MRI findings in schizophrenia. Schizophr Res 49: 1-52. (Pubitemid 32451739)
4. Suzuki M, Nohara S, Hagino H, Kurokawa K, Yotsutsuji T, et al. (2002) Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. Schizophr Res 55: 41-54. (Pubitemid 34310535)
5. Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160: 636-645. (Pubitemid 41079594)
6. Keshavan MS, Prasad KM, Pearlson G (2007) Are brain structural abnormalities useful as endophenotypes in schizophrenia? Int Rev Psychiatry 19: 397-406.
7. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, et al. (2000) Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9: 1415-1423. (Pubitemid 30312490)
8. St Clair D, Blackwood D, Muir W, Carothers A, Walker M, et al. (1990) Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336: 13-16. (Pubitemid 20207869)
9. James R, Adams RR, Christie S, Buchanan SR, Porteous DJ, et al. (2004) Disrupted in Schizophrenia 1 (DISC1) is a multicompartmentalized protein that predominantly localizes to mitochondria. Mol Cell Neurosci 26: 112-122. (Pubitemid 38581027)
10. Kamiya A, Kubo K, Tomoda T, Takaki M, Youn R, et al. (2005) A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex development. Nat Cell Biol 7: 1167-1178.
11. Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, et al. (2006) DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol 497: 436-450. (Pubitemid 43865795)
12. Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, et al. (2003) Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100: 289-294. (Pubitemid 36078067)
13. Taya S, Shinoda T, Tsuboi D, Asaki J, Nagai K, et al. (2007) DISC1 regulates the transport of the NUDEL/LIS1/14-3-3epsilon complex through kinesin-1. J Neurosci 27: 15-26. (Pubitemid 46089955)
14. Ishizuka K, Paek M, Kamiya A, Sawa A (2006) A review of Disrupted-in-Schizophrenia-1 (DISC1): neurodevelopment, cognition, and mental conditions. Biol Psychiatry 59: 1189-1197.
15. Roberts RC (2007) Schizophrenia in translation: disrupted in schizophrenia (DISC1): integrating clinical and basic findings. Schizophr Bull 33: 11-15.
16. Callicott JH, Straub RE, Pezawas L, Egan MF, Mattay VS, et al. (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 102: 8627-8632. (Pubitemid 40862786)
17. Hashimoto R, Numakawa T, Ohnishi T, Kumamaru E, Yagasaki Y, et al. (2006) Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15: 3024-3033. (Pubitemid 44530706)
18. Takahashi T, Suzuki M, Tsunoda M, Maeno N, Kawasaki Y, et al. (2009a) The Disrupted-in-Schizophrenia-1 Ser704Cys polymorphism and brain morphology in schizophrenia. Psychiatry Res 172: 128-135.
19. Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 147: 1-13.
20. Sullivan PF (2013) Questions about DISC1 as a genetic risk factor for schizophrenia. Mol Psychiatry 18: 1050-1052.
21. Toyo-oka K, Shionoya A, Gambello MJ, Cardoso C, Leventer R, et al. (2003) 14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome. Nat Genet 34: 274-285. (Pubitemid 36792859)
22. Ikeda M, Hikita T, Taya S, Uraguchi-Asaki J, Toyo-oka K, et al. (2008) Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia. Hum Mol Genet 17: 3212-2322.
23. Goldman-Rakic PS (1994) Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci 6: 348-357.
24. World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. World Health Organization, Geneva.
25. Andreasen NC, Flaum M, Arndt S (1992) The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49: 615-623.
26. Andreasen NC (1984a) Scale for the assessment of negative symptoms (SANS). University of Iowa, Iowa City.
27. Andreasen NC (1984b) Scale for the assessment of positive symptoms (SAPS). University of Iowa, Iowa City.
28. Ashburner J, Friston KJ (2005) Unified segmentation. NeuroImage 26: 839-851. (Pubitemid 40825026)
29. Ashburner J (2007) A fast diffeomorphic image registration algorithm. NeuroImage 38: 95-113.
30. Jones DK, Symms MR, Cercignani M, Howard RJ (2005) The effect of filter size on VBM analyses of DT-MRI data. Neuroimage 26: 546-554. (Pubitemid 40719832)
31. Salmond CH, Ashburner J, Vargha-Khadem F, Connelly A, Gadian DG, et al. (2002) Distributional assumptions in voxel-based morphometry. Neuroimage 17: 1027-1030. (Pubitemid 35317035)
32. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003) An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 19: 1233-1239. (Pubitemid 36918259)
33. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, et al. (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15: 273-289. (Pubitemid 34852226)
34. Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. 3-Dimensional proportional system: an approach to cerebral imaging. Stuttgart Thieme.
35. Lancaster JL, Summerln JL, Rainey L, Freitas CS, Fox PT (1997) The Talairach Daemon, a database server for Talairach Atlas Labels. NeuroImage 5: S633. (Pubitemid 127699782)
36. Lancaster JL, Woldorff MG, Parsons LM, Liotti M, Freitas CS, et al. (2000) Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp 10: 120-131. (Pubitemid 30456920)
37. Toru M (2008) Psychotropic Manual, Third Edition. Igaku-shoin, Tokyo. (in Japanese).
38. Wylie KP, Tregellas JR (2010) The role of the insula in schizophrenia. Schizophr Res 123: 93-104.
39. Augustine JR (1996) Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev 22: 229-244.
40. Glahn DC, Laird AR, Ellison-Wright I, Thelen SM, Robinson JL, et al. (2008) Meta-analysis of gray matter anomalies in schizophrenia: application of anatomic likelihood estimation and network analysis. Biol Psychiatry 64: 774-781.
41. Shepherd AM, Matheson SL, Laurens KR, Carr VJ, Green MJ (2012) Systematic meta-analysis of insula volume in schizophrenia. Biol Psychiatry 72: 775-784.
42. Palaniyappan L, Liddle PF (2012) Aberrant cortical gyrification in schizophrenia: a surface-based morphometry study. J Psychiatry Neurosci 37: 399-406.
43. Jakob H, Beckmann H (1986) Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65: 303-326. (Pubitemid 16073151)
44. Pennington K, Dicker P, Hudson L, Cotter DR (2008) Evidence for reduced neuronal somal size within the insular cortex in schizophrenia, but not in affective disorders. Schizophr Res 106: 164-171.
45. Borgwardt SJ, Riecher-Rössler A, Dazzan P, Chitnis X, Aston J, et al. (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61: 1148-1156. (Pubitemid 46669460)
46. Takahashi T, Wood SJ, Yung AR, Phillips LJ, Soulsby B, et al. (2009b) Insular cortex gray matter changes in individuals at ultra-high-risk of developing psychosis. Schizophr Res 111: 94-102.
47. Borgwardt SJ, Picchioni MM, Ettinger U, Toulopoulou T, Murray R, et al. (2010) Regional gray matter volume in monozygotic twins concordant and discordant for schizophrenia. Biol Psychiatry 67: 956-964.
48. Chakravarty MM, Felsky D, Tampakeras M, Lerch JP, Mulsant BH, et al. (2012) DISC1 and Striatal Volume: A Potential Risk Phenotype For mental Illness. Front Psychiatry 3: 57.
49. Lipina TV, Niwa M, Jaaro-Peled H, Fletcher PJ, Seeman P, et al. (2010) Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav 9: 777-789.
50. Ballmaier M, Schlagenhauf F, Toga AW, Gallinat J, Koslowski M, et al. (2008) Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res 106: 140-147.
51. Glenthoj A, Glenthoj BY, Mackeprang T, Pagsberg AK, Hemmingsen RP, et al. (2007) Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug. Psychiatry Res 154: 199-208. (Pubitemid 46428524)
52. Gunduz H, Wu H, Ashtari M, Bogerts B, Crandall D, et al. (2002) Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjects. Biol Psychiatry 51: 801-808. (Pubitemid 34451067)
53. Li M, Chen Z, Deng W, He Z, Wang Q, et al. (2011) Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. Psychol Med 42: 1475-1483.
54. Ebdrup BH, Skimminge A, Rasmussen H, Aggernaes B, Oranje B, et al. (2011) Progressive striatal and hippocampal volume loss in initially antipsychotic-naive, first-episode schizophrenia patients treated with quetiapine: relationship to dose and symptoms. Int J Neuropsychopharmacol 14: 69-82.
55. Borgwardt S, Smieskova R, Fusar-Poli P (2012) Gray matter pathology of hippocampus - a specific endophenotype for schizophrenia? Psychiatry Res 202: 273-274.
56. Lipska BK, Peters T, Hyde TM, Halim N, Horowitz C, et al. (2006) Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. Hum Mol Genet 15: 1245-1258.
57. Bis JC, DeCarli C, Smith AV, van der Lijn F, Crivello F, et al. (2012) Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet 44: 545-551.
58. Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, et al. (2012) Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet 44: 552-561.
59. Sekiguchi H, Iritani S, Habuchi C, Torii Y, Kuroda K, et al. (2011) Impairment of the tyrosine hydroxylase neuronal network in the orbitofrontal cortex of a genetically modified mouse model of schizophrenia. Brain Res 1392: 47-53.
60. Haijma SV, Van Haren N, Cahn W, Koolschijn PC, Hulshoff Pol HE, et al. (2013) Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull 39: 1129-1138.
61. Andreasen NC, Liu D, Ziebell S, Vora A, Ho BC (2013) Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry 170: 609-615.
62. Lieberman JA, Tollefson GD, Charles C, Zipursky R, Sharma T, et al. (2005) Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry 62: 361-370. (Pubitemid 40471685)
63. Anderson D, Ardekani BA, Burdick KE, Robinson DG, John M, et al. (2013) Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder. Bipolar Disord 15: 680-693.